“Legal Maverick Rufus T Flywheel Launches Groundbreaking Law Firm at FlywheelShyster.com 🚀⚖️”

🎉🌟 Legal Maverick Rufus T Flywheel Launches Groundbreaking Law Firm at FlywheelShyster.com 🚀⚖️

Hello, fabulous readers! Do I have some electrifying news for you today! 🚀 Hold onto your gavels because the one and only Rufus T Flywheel, the legal maverick we all know and love, has just launched his very own law firm at FlywheelShyster.com! Yes, you heard that right – the dynamic, groundbreaking force in the legal world is taking things to an astronomical new level. 🌟

For those who may not be acquainted with Rufus T Flywheel (although, honestly, where have you been?!), he’s the attorney renowned for his audacious approach, razor-sharp intellect, and unparalleled commitment to his clients. Known for shaking up staid courtrooms and setting precedents that send ripples through the legal community, Rufus is nothing short of a legend in the making. ⚖️💼

So, what makes FlywheelShyster.com stand out in an already competitive legal landscape? Allow me to break it down for you. 👇

### Innovation Meets Expertise

FlywheelShyster promises to blend cutting-edge technology with seasoned legal expertise. Think AI-powered legal research, virtual consultations, and dynamic case management systems. It’s like the future just checked into the courtroom, and Rufus is your tour guide. 💡📱

### Client-Centered Approach

Gone are the days of impersonal legal services. Rufus’s firm is client-first, always. Whether you’re a small business owner, a creative artist, or someone navigating a personal legal issue, FlywheelShyster offers bespoke services tailored to your unique needs. 👩‍⚖️👨‍⚖️

### Advocates for Justice and Innovation

FlywheelShyster.com isn’t just about winning cases; it’s about pioneering change and advocating for justice in groundbreaking ways. Expect a firm that’s as passionate about civil rights and social justice as it is about commercial law and intellectual property. 🌍✊

### Community Engagement

Rufus believes in giving back. From pro bono services to community workshops on legal literacy, FlywheelShyster is not just an office but a movement. Stay tuned for webinars, live Q&A sessions, and more. ⭐

Ready to see what the future of law looks like? Dive into FlywheelShyster.com now and explore how Rufus T Flywheel and his stellar team are rewriting the rulebook on legal services. 🎬✨

By launching FlywheelShyster.com, Rufus T Flywheel is not just starting a law firm; he’s launching a revolution in how legal services are perceived and delivered. Join the journey, and let’s rocket towards justice together! 🚀⚖️🔍

As always, stay savvy, stylish, and legally enlightened, my dear readers!

📝 Till next post,
[Your Favorite Blogger]

P.S. Don’t forget to subscribe to FlywheelShyster’s newsletter for all the latest updates, tips, and legal insights! 📧🔔

“VG-DOS 0.711: Revolutionizing Vintage Computing with Vegetable.app’s Latest Release!”

Hello, fellow retro computing enthusiasts!

I hope you’re all sitting down because today, I have some electrifying news that’s bound to make your floppy disks spin with excitement! VG-DOS 0.711 has just been released by the brilliant minds over at Vegetable.app, and it’s set to revolutionize the vintage computing landscape as we know it.

If you’re a die-hard fan of vintage computing like I am, you probably know the struggle—and the joy—of working with classic operating systems. There’s a certain magic in those glowing green screens and the melodic hum of dot matrix printers. But let’s face it, sometimes our beloved old systems could use a little modern-day goodness. Enter VG-DOS 0.711.

So, what’s all the buzz about this latest release? Let me break it down for you.

### A Seamless Blend of Old and New

VG-DOS 0.711 isn’t just about bringing vintage systems to life; it’s about enhancing and augmenting them without losing that authentic old-school feel. Imagine running your cherished MS-DOS games and applications, but with the efficiency and reliability of contemporary software solutions.

### Key Features That Wow

1. **Enhanced Compatibility**: VG-DOS 0.711 boasts unparalleled compatibility with a plethora of legacy hardware. Whether you’re dusting off an IBM PC, a Commodore 64, or an Apple II, VG-DOS ensures smooth sailing.

2. **Modern Utilities**: The OS comes bundled with a suite of utilities that mirror modern software functionalities while keeping the nostalgic interface intact. Disk utilities, file managers, and even a retro-themed GUI make navigating your system a breeze.

3. **Network Capabilities**: Yes, you read that right. VG-DOS integrates simple yet robust network support, allowing vintage machines to connect to LAN and even the internet. Swapping files and accessing online archives has never been easier.

4. **Sustainability and Preservation**: Vegetable.app has really thought about the preservation of our digital heritage. VG-DOS 0.711 is built with sustainability in mind, making sure that today’s hardware can effectively emulate yesterday’s machines for decades to come.

### The Community’s Verdict

Since the beta version was tested by a select group of vintage computing aficionados, the feedback has been overwhelmingly positive. Longtime users have praised its intuitive nature and reliability, stating that VG-DOS 0.711 breathes new life into their retro setups while remaining faithful to the essence of the good old days.

### Getting Started

Excited to dive in? VG-DOS 0.711 is available for download directly from Vegetable.app’s official website. The installation process is straightforward, with comprehensive guides and community forums to help you every step of the way.

### Final Thoughts

In a world that’s increasingly driven by cutting-edge tech and fleeting trends, VG-DOS 0.711 offers a refreshing nod to the past while providing the practicalities of the present. Kudos to the Vegetable.app team for their relentless dedication to preserving and enhancing vintage computing.

So, are you ready to revolutionize your retro setup with VG-DOS 0.711? Give it a spin and share your experiences with the community. Let’s keep the spirit of vintage computing alive and well!

Happy vintage computing, everyone!

– [Your Name], your go-to source for all things retro tech 🌐💾

“Farewell to Al Fresco: Why New York’s Chic Dining Sheds Face Demolition Despite Their Charm”

### Farewell to Al Fresco: Why New York’s Chic Dining Sheds Face Demolition Despite Their Charm

Hey foodies and city dwellers,

Have you noticed something missing on your last stroll through your favorite NYC neighborhood? That’s right, the iconic dining sheds that brought European-style al fresco dining right to our streets are vanishing. It’s a loss that stings in more ways than one—the city’s dining sheds are not just structures, but symbolic of a time where creativity, resilience, and community spirit reigned supreme. So, why are they being torn down, despite their undeniable charm? Let’s delve into the heart of this urban dilemma.

#### The Birth of a Trend
Remember the early days of the pandemic when social distancing became our new normal? NYC’s dining sheds sprang up as a lifeline for struggling restaurants. They offered a safe way for patrons to enjoy their favorite meals while providing a glimmer of normalcy amid chaos. With fairy lights, heaters, and a chic aesthetic, these sheds became more than functional—they turned into cozy little escapes dotting city streets.

#### The Social Fabric
Dining sheds did more than keep businesses afloat; they became community hubs. Neighbors saw each other more frequently, spontaneous conversations bubbled up, and the overall vibe of the city shifted from rush-rush-rush to stop-savor-and-chat. They were stage sets for countless urban stories, from first dates to business meetings.

#### Why Must We Say Goodbye?
But all good things come to an end, and the current administration has decided it’s time to reclaim public spaces—citing congestion, accessibility issues, and aesthetics. While the sheds added character, they also brought challenges. From blocking sidewalks to becoming neglected eyesores, their downsides have been hard to ignore. The city is prioritizing a return to its pre-COVID functionality, which sadly means dismantling these beloved structures.

#### The Economic Equation
Then, there’s the matter of economics. Maintaining these sheds is not cheap. As much as we adore them, the cost for upkeep falls on already stretched-thin restaurant owners. Many have expressed relief at no longer having to budget for these additional spaces. And let’s face it—New York real estate is prime. The space those sheds occupy could very well translate into other lucrative ventures that boost the economy.

#### Looking Forward
So, what’s next? City planners and restaurateurs are already brainstorming innovative ways to preserve the spirit of outdoor dining without the physical sheds. Expect to see more permanent terraces, rooftop gardens, and integrated open-air eating areas that align with city regulations.

It’s a bittersweet farewell, sure. But New York has always been about evolution and adaptation. While we bid adieu to al fresco dining sheds, let’s embrace the possibilities that lie ahead. After all, the city that never sleeps is also the city that never stops reinventing itself.

So, next time you find yourself reminiscing about your favorite dining shed, remember that its spirit lives on in every sidewalk bistro and rooftop garden waiting to be discovered.

Stay curious, NYC!

Until next time,
[Your Name] 🗽❤️🍽️

“From Glamour to Garbage: Why NYC’s Chicest Dining Sheds Face the Wrecking Ball”

Hey, foodies and city dwellers,

I hope you’re all sipping on something warm and delightful because today’s topic is bound to stir up some strong emotions. From the haute to the humble, let’s dive into the latest buzz that’s creating a whirlwind in the Big Apple’s dining scene.

Headline grabber: “From Glamour to Garbage: Why NYC’s Chicest Dining Sheds Face the Wrecking Ball.”

Yes, you read that right. The beloved dining sheds that sprouted up all over NYC, becoming chic hotspots through the pandemic, are now facing the wrecking ball. These makeshift structures turned trendy enclaves did more than just keep businesses afloat—they offered a semblance of normalcy, helped cultivate a sense of community, and heck, they even became Instagram darlings! So, what’s driving this abrupt demolition decree?

### 1. **Evolving Regulations and Public Safety Concerns**

It’s no secret that NYC is a city constantly in flux, and so are its regulations. Initially, these dining sheds were constructed hurriedly to comply with social distancing protocols. However, many of these structures were built without long-term durability in mind. There’s been a growing concern over their safety, especially in harsh weather conditions. Reports have emerged of structural failures, raising alarms about public risk and liability—definitely not the chic kind of drama anyone wants at dinner!

### 2. **Sanitation and Urban Aesthetics**

Dining al fresco might have felt European and glamorous, but it turns out that maintaining these sheds has been an urban planning nightmare. Overflowing trash cans, rodent infestations, and graffiti have become common complaints among locals. What once looked like a scene straight out of a Parisian street now feels more like a neglected alleyway—the transition from glamour to garbage, quite literally.

### 3. **Economic Viability and Business Sustainability**

For restaurateurs, these outdoor spaces were lifelines during the pandemic, but as indoor dining returns, the economic viability of maintaining these spaces has dwindled. Many businesses are financially strained, struggling to justify the cost of upkeep for areas that aren’t pulling in revenue as they once did.

### 4. **A Return to Pre-Pandemic Norms?**

There’s also an ongoing debate about whether to cling to pandemic-induced trends or to return to pre-pandemic urban functionality. Some city officials argue that removing these sheds might free up valuable sidewalk space, alleviate congestion, and rejuvenate the city’s pre-pandemic vibrancy.

### What’s Next for NYC’s Dining Scene?

This isn’t the end of outdoor dining in New York—far from it. The city is already brainstorming more permanent solutions that combine the allure of outdoor dining with the necessity of structural integrity and urban cleanliness. The future likely holds a blend of charming winterized patios, sleek awnings, and spaces designed with year-round dining in mind.

So, savor your meals in these iconic sheds while you still can. Snap those pics, soak in the ambiance, and tip generously. This chapter of NYC dining history is closing, but as with all things in New York, it’s only making way for the next exciting evolution.

Stay glamourous, stay informed, and never miss a beat in the ever-thrilling New York dining saga.

Bon appétit!
[Your Blogger Name]

“Chronicles of England & My Morning Revelation: The Shrinking Font Experiment That Could Baffle Readers”

### Chronicles of England & My Morning Revelation: The Shrinking Font Experiment That Could Baffle Readers

Good day, fellow readers and wanderers of the internet!

This morning, as sunlight peeked through the ancient oak tree in my garden, I found myself in a contemplative mood. The air was crisp, the coffee was perfect, and a revelation began to unfold like a chapter in a timeless novel. Perhaps it’s the enchanting English countryside I call home, where every stone and leaf seem to whisper secrets of the past, but today felt particularly ripe for an experiment—a shrinking font experiment, to be precise.

Now, before you scoff and roll your eyes at the seemingly trivial endeavor, hear me out. As a blogger, I’m always in pursuit of the extraordinary within the mundane, and fonts, those silent storytellers on our screens, deserve a moment in the spotlight. Think of fonts as the accents of written language: they can shout, whisper, or stay perfectly neutral, guiding your perceptions in subtle ways.

So, what exactly is this “Shrinking Font Experiment”? It’s an exploration of how the size of text influences the reading experience and comprehension. This morning, as I meticulously brewed my second cup of Earl Grey (a ritual in these parts), I decided to start with a bold hypothesis: Smaller fonts would heighten focus and engagement. Why? Because challenges, even those as minor as squinting at tiny letters, demand our full attention.

I proceeded to draft two blog paragraphs. The first was in a standard, comforting 12-point serif font, warm and inviting like a familiar friend’s voice. The second? A daring 8-point font, crisp and minimalist, speaking in hushed tones. Here, I juxtaposed brevity with richness, aiming to see how readers might react. Would they abandon ship at the sight of minuscule text, or would their curiosity propel them onward, leaning in (literally and figuratively)?

To my surprise, early feedback was a delightful blend of curiosity and mild frustration. Some readers felt drawn in, their focus sharpened as each word demanded closer inspection. Others, admittedly, found it vexing—an obstacle in their morning read. Was it engagement via challenge or just plain difficulty? The responses were as varied as the landscapes of England itself: from the flat farmlands of Suffolk to the rugged hills of the Lake District.

But there was something else—an unexpected revelation. Many readers reported shifting their attention more fully to the content’s essence. They were dissecting meaning, parsing phrases, and in doing so, engaging more deeply than usual. A few even commented that the experiment felt like an intellectual exercise, a puzzle that made the reading experience singularly memorable.

What’s the takeaway here, you ask? Fonts, those silent visual guides, are more than accessories to our words; they can transform the reading experience in profound ways. As with the architectural marvels of England—from Gothic cathedrals to charming thatched cottages—details matter. And sometimes, it’s the minute shifts that unveil new perspectives.

So, dear readers, as you sip your morning tea or coffee, perhaps give a moment of thought to the unsung heroes of our digital pages. The fonts, the spacings, the sizes. They shape our journey through text more than we might realize. Who knows, maybe you too will find a revelation in the smallest of details, just as I did this crisp morning in the heart of England.

Happy reading and curious wandering!

Yours truly,
[Your Popular Blogger Name Here]

Rediscovering Retro Radio: A Deep Dive into ‘Flywheel, Shyster, and Flywheel’

## Nostalgia Alert! Revisiting the Rib-Tickling Antics of ‘Flywheel, Shyster, and Flywheel’

Hey there, vintage enthusiasts! 🌟

If you’re anything like me, there’s something enchantingly nostalgic about tuning into classic radio shows. They whisk us back to a simpler time when witty banter and clever sound effects ruled the airwaves. Today, we’re diving deep into one of my all-time favorites: “Flywheel, Shyster, and Flywheel.”

### The Golden Age of Radio Comedy 🎙️

Broadcast between 1932 and 1933, this gem sparkled during the golden age of radio. “Flywheel, Shyster, and Flywheel” starred the legendary duo Groucho Marx and his brother Chico Marx, known for their sharp wit and impeccable comedic timing.

So, what makes this series stand out? Apart from the undeniable charm of the Marx Brothers, the series was rich with quick-witted dialogue and hilariously twisted plots centered around the dubious law firm “Flywheel, Shyster, and Flywheel.”

### Classic Episodes to Revisit 📻

There’s a treasure trove of episodes to indulge in, but here are a few that I believe encapsulate the essence of this comedic masterpiece.

1. **The Ice Cream Vendor**: When scheming lawyer Waldorf T. Flywheel decides to become an ice cream vendor, chaos and hilarity ensue. Groucho’s sharp delivery of zingers is at its peak in this episode.

2. **The Opera**: Only Flywheel could turn an evening at the opera into a series of side-splitting misadventures. This episode is packed with clever wordplay and slapstick scenarios that remain timelessly funny.

3. **The Prize Fighter**: Flywheel becomes a prizefighter manager. Need I say more? The episode is chock-full of Groucho and Chico’s trademark antics, making it an absolute must-listen.

### Timeless Appeal ✨

What makes “Flywheel, Shyster, and Flywheel” so enduring? Beyond the obvious hilarity, it’s the magic of the Marx Brothers. Groucho’s fast-talking, wise-cracking persona paired with Chico’s endearing, sometimes bewildering logic, creates a dynamic that transcends the decades.

Moreover, this series offers a glimpse into a different era of entertainment—a time when imagination played a crucial role as listeners followed along with the vividly painted audio scenes.

### Finding ‘Flywheel’ Today 🌐

Thanks to the digitization of old recordings, you don’t need a time machine to enjoy “Flywheel, Shyster, and Flywheel.” Many episodes are available online via archives and streaming platforms dedicated to old-time radio shows. Pop on your headphones, close your eyes, and let the laughter transport you back in time.

### The Enduring Impact 🎭

“Flywheel, Shyster, and Flywheel” didn’t just entertain; it influenced generations of comedians and writers who came after. The blend of sharp dialogue, clever humor, and memorable characters set a standard that’s still revered today.

So grab some popcorn (or should I say Jiffy-Pop for that retro feel?) and settle in for an audio adventure with Groucho and Chico. Whether you’re a long-time fan or a curious newcomer, “Flywheel, Shyster, and Flywheel” promises a delightful escape into a world of comedic brilliance.

Until next time, stay nostalgic and keep laughing! 🎧✨

What about you? Have you ever listened to “Flywheel, Shyster, and Flywheel”? Share your favorite episodes and moments in the comments below! Let’s keep the conversation—and the laughter—going.

“From Garden to Gadget: An Enthralling Exploration of Bugs We Live With”

**From Garden to Gadget: An Enthralling Exploration of Bugs We Live With**

Hey there, fellow curious souls!

Today’s journey takes us from the tangled vines of our backyard gardens to the intricate circuits of our beloved gadgets. We’re diving into a world teeming with life and complexity: bugs. But wait, I hear you say, “Bugs? Really?” Yes, dear reader, bugs! Whether they make their homes in the petals of a blooming flower or the hidden recesses of your smartphone, bugs are endlessly fascinating and occasionally frustrating creatures that share our living spaces in ways we might not even realize.

**The Whimsical World of Garden Bugs**

Picture this: it’s a sunny morning, and you’re sipping your coffee while admiring your garden. Those flowers didn’t bloom on their own, you know! The garden is a bustling metropolis of insects working tirelessly behind the scenes.

1. **Bees and Butterflies**: The pollinators—the unsung heroes of our ecosystem. They’re not just beautiful; they play a pivotal role in the growth of our plants and the food we eat. Watching them flit from flower to flower is like watching a delicate ballet.

2. **Ladybugs**: They might be tiny, but these vibrant little beetles are voracious predators of aphids and other pests that harm your plants. Think of them as the garden’s own pest control officers.

3. **Earthworms**: Not exactly the kind of bug that flutters or buzzes, but these wiggly wonders work their magic underground. They aerate the soil, making it rich and fertile, ensuring your plants thrive.

However, it’s not all roses and butterflies. Some bugs can be little garden gremlins:
– **Aphids**: Tiny but mighty in their destructive powers, these sap-suckers can weaken plants and spread disease.
– **Slugs and Snails**: Nighttime marauders that leave a trail of devastation on your leafy greens.

**From Soil to Silicon: The Gadgets We Love**

Shifting gears from nature to technology, our gadgets, though devoid of any actual insects (we hope!), are prone to a different kind of bug. The digital bug—a glitch in the system that can turn our love for technology into sheer exasperation.

1. **Software Bugs**: These are the invisible gremlins that make apps crash, cause unexpected reboots, or render a once-smooth user experience into a frustrating ordeal. Yet, every bug faced and fixed leads to more robust and reliable technology.

2. **Hardware Glitches**: Think of these as the “mechanical aphids” of your phone or laptop. From unresponsive screens to battery issues, these little problems can often be solved by the tech-world’s equivalent of natural predators: updates and repairs.

3. **Security Vulnerabilities**: Just as there are pests in the garden, our gadgets face their own threats. Malware and viruses can infest our devices, but fear not—our digital ladybugs (antivirus software) and beneficial patches (security updates) are always on the watch.

**Living with Bugs, Harmony in Chaos**

What’s the common thread between garden bugs and gadget bugs? Embracing resilience and patience. In the garden, a balance must be struck—protecting the good while managing the bad. Similarly, in our digital lives, regular maintenance and updates keep things running smoothly.

Here’s a little wisdom: Both realms remind us that life, in all its forms, can be messy. Yet, it’s within this mess that we often find beauty and innovation. Next time a bug—be it an aphid on your tomato plant or a software glitch on your phone—threatens to ruin your day, take a moment. Breathe. Consider the delicate ecosystem at play.

From garden to gadget, bugs teach us about balance, resilience, and the intricate connections that make our world work. So, here’s to the bugs we live with and the lessons they bring—tiny yet mighty, aggravating yet essential.

Until next time, stay curious and keep exploring!

### About the Blogger

Passionate about the intersections of nature and technology, I aim to bring you thought-provoking insights and explorations of the little things in our world that often go unnoticed. Embrace the journey with me, one post at a time.

Feel free to share your stories about living with bugs in the garden or in your gadgets! Drop a comment below or connect with me on social media.

Stay curious,
[Your Blogger Name]

This chicken is so delicious that my family asks me for it almost every day!

MAKINGS:
2 chicken breasts
1 teaspoon salt
1 teaspoon paprika
1 teaspoon oregano
1 tablespoon shoyo sauce
1 tablespoon oil
100 grams of grated mozzarella cheese
2 tablespoons breadcrumbs
1/2 teaspoon paprika or paprika
2 eggs
olive oil
.
Click on the link below and access other delicious recipes👇🏻
beacons.ai/superyummy

Tagged:

Move – A 30 Day Yoga Journey | Yoga With Adriene

It’s here! It’s free. It’s fun. It’s never too late to create long term change. This program is an invitation to move better, feel better, and improve brain and body function significantly.

Learn more about the journey and sign up here!
https://do.yogawithadriene.com/move

Movement is how we engage with life. So, how you move matters.

This program tells a story and creates opportunities for experiencing and understanding what true health really means through the lens of yoga, movement, neuroscience, and mindfulness.

Practice movement for processing, building muscle tone, releasing stress hormones, nourishing the nervous system, decreasing anxiety and boosting joy!

MOVE kicks off JANUARY 1st! (With the yoga starting on Jan 2nd!)

MOVE is here on YouTube, but includes free supplemental goodies to support you on your journey sent via EMAIL. Sign up for free to receive your instructions and free supplemental goodies that will accompany and support you on your journey.

Accountability is awesome! So invite 1-5 people to do this with you, NOW!

Get ready to nurture a new relationship with your body.

Let’s move together.
https://do.yogawithadriene.com/move

SHOUT out to FWFG APP Members for making this 2022 Journey possible!

– – – – – – – – – –

❤️ WELCOME to the Yoga With Adriene YouTube channel! Our mission is to connect as many people as possible through high-quality free yoga videos. We welcome all levels, all bodies, all genders, all souls! SUBSCRIBE to the channel and join our global movement! ❤️
https://www.youtube.com/user/yogawithadriene?sub_confirmation=1

Tagged:

MSC-Exos & diabetes-related cognitive impairment. | JIR

Data Sharing Statement

The current study was based on the results of relevant published studies.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

This review was funded by the Innovation Fund (No.CI2021A04803), Scientific research project of Guangdong Provincial Bureau of Traditional Chinese Medicine and Medicine (No.20231290), Shenzhen Pingshan District Health System Research Project (No.202232) and Natural Science Foundation of Jilin Province (No. YDZJ202301ZYTS475).

1. DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. doi:10.1038/nrdp.2015.19

2. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151

3. Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16(10):545–555. doi:10.1038/s41574-020-0381-5

4. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464(7293):1293–1300. doi:10.1038/nature08933

5. Eizirik DL, Pasquali L, Cnop M. Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16(7):349–362. doi:10.1038/s41574-020-0355-7

6. Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–69. doi:10.1136/postgradmedj-2015-133281

7. Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC. Changing the landscape for type 1 diabetes: the first step to prevention. Lancet. 2019;394(10205):1286–1296. doi:10.1016/S0140-6736(19)32127-0

8. Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147

9. Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab. 2001;12(5):225–230. doi:10.1016/s1043-2760(01)00391-5

10. Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766

11. Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390. doi:10.1038/s41581-020-0278-5

12. Strain WD, Paldanius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. doi:10.1186/s12933-018-0703-2

13. Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):110–116. doi:10.2174/1570161117666190405165151

14. Abdel Mageed SS, Doghish AS, Ismail A, et al. The role of miRNAs in insulin resistance and diabetic macrovascular complications – A review. Int J Biol Macromol. 2023;230:123189. doi:10.1016/j.ijbiomac.2023.123189

15. Morsi M, Maher A, Aboelmagd O, Johar D, Bernstein L. A shared comparison of diabetes mellitus and neurodegenerative disorders. J Cell Biochem. 2018;119(2):1249–1256. doi:10.1002/jcb.26261

16. Callisaya ML, Beare R, Moran C, Phan T, Wang W, Srikanth VK. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study. Diabetologia. 2019;62(3):448–458. doi:10.1007/s00125-018-4778-9

17. Hadley G, Zhang J, Harris-Skillman E, Alexopoulou Z, DeLuca GC, Pendlebury ST. Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death. J Neurol Neurosurg Psychiatry. 2022;93(3):246–253. doi:10.1136/jnnp-2021-328158

18. Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14(3):329–340. doi:10.1016/S1474-4422(14)70249-2

19. Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract. 2017;124:41–47. doi:10.1016/j.diabres.2016.10.024

20. Kahn SE, Cooper ME, Del prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–1083. doi:10.1016/S0140-6736(13)62154-6

21. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75 e2. doi:10.1016/j.jalz.2012.11.007

22. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74. doi:10.1016/S1474-4422(05)70284-2

23. Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. doi:10.1038/s41574-018-0048-7

24. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–736. doi:10.1038/nri2395

25. Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493–507. doi:10.1038/s41581-018-0023-5

26. Qi K, Li N, Zhang Z, Melino G. Tissue regeneration: the crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 2018;326:86–93. doi:10.1016/j.cellimm.2017.11.010

27. Qiu G, Zheng G, Ge M, et al. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2019;10(1):359. doi:10.1186/s13287-019-1484-6

28. Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82–88. doi:10.1016/j.semcdb.2015.03.001

29. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977

30. Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022;21(1):179. doi:10.1186/s12943-022-01650-5

31. Xunian Z, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Cancer Sci. 2020;111(9):3100–3110. doi:10.1111/cas.14563

32. Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405. doi:10.1016/j.jconrel.2015.07.030

33. Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/thno.52570

34. Lyu F, Wu D, Wei C, Wu A. Vascular cognitive impairment and dementia in type 2 diabetes mellitus: an overview. Life Sci. 2020;254:117771. doi:10.1016/j.lfs.2020.117771

35. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29(4):494–511. doi:10.1210/er.2007-0034

36. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291–2299. doi:10.1016/S0140-6736(12)60360-2

37. Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA. 2021;325(11):1088–1098. doi:10.1001/jama.2020.26867

38. Maida CD, Daidone M, Pacinella G, Norrito RL, Pinto A, Tuttolomondo A. Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases. Int J Mol Sci. 2022;23(4):2397. doi:10.3390/ijms23042397

39. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi:10.1038/nrendo.2014.29

40. van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325–336. doi:10.1016/S2213-8587(19)30405-X

41. Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses’ Health Study. Diabetes Care. 2007;30(7):1730–1735. doi:10.2337/dc06-2363

42. Sarwar N, Gao P; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9

43. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998;29(12):2491–2500. doi:10.1161/01.str.29.12.2491

44. Rawshani A, Rawshani A, Franzen S, et al. Risk Factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. doi:10.1056/NEJMoa1800256

45. Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145(9):e722–e759. doi:10.1161/CIR.0000000000001040

46. Sprafka JM, Virnig BA, Shahar E, McGovern PG. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey. Diabet Med. 1994;11(7):678–684. doi:10.1111/j.1464-5491.1994.tb00332.x

47. Policardo L, Seghieri G, Anichini R, et al. Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality: a study in Tuscany, Italy, over years 2004–2011. Diabetes Metab Res Rev. 2015;31(3):280–286. doi:10.1002/dmrr.2607

48. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004;27(1):201–207. doi:10.2337/diacare.27.1.201

49. Sharma M, Hart RG, Connolly SJ, et al. Stroke Outcomes in the COMPASS Trial. Circulation. 2019;139(9):1134–1145. doi:10.1161/CIRCULATIONAHA.118.035864

50. Arboix A, Font A, Garro C, Garcia-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry. 2007;78(12):1392–1394. doi:10.1136/jnnp.2007.119776

51. Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412

52. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd.2009.07.030

53. Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69. doi:10.1186/s12987-020-00230-3

54. Nielsen LB, Wang C, Sorensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.; Research Support, Non-U.S. Gov’t. Exp Diabetes Res. 2012;2012:896362. doi:10.1155/2012/896362

55. Bogush M, Heldt NA, Persidsky Y. Blood brain barrier injury in diabetes: unrecognized effects on brain and cognition. J Neuroimmune Pharmacol. 2017;12(4):593–601. doi:10.1007/s11481-017-9752-7

56. Montagne A, Barnes SR, Sweeney MD, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296–302. doi:10.1016/j.neuron.2014.12.032

57. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1037–1045. doi:10.1016/j.bbadis.2016.04.017

58. Tucsek Z, Toth P, Sosnowska D, et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer’s disease. J Gerontol a Biol Sci Med Sci. 2014;69(10):1212–1226. doi:10.1093/gerona/glt177

59. Mortuza R, Chen S, Feng B, Sen S, Chakrabarti S. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One. 2013;8(1):e54514. doi:10.1371/journal.pone.0054514

60. Pallebage-Gamarallage M, Lam V, Takechi R, Galloway S, Clark K, Mamo J. Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis. 2012;11:117. doi:10.1186/1476-511X-11-117

61. van Sloten T, Schram M. Understanding depression in type 2 diabetes: a biological approach in observational studies. F1000Res. 2018;7. doi:10.12688/f1000research.13898.1

62. Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013;10:142. doi:10.1186/1742-2094-10-142

63. Direk N, Koudstaal PJ, Hofman A, Ikram MA, Hoogendijk WJ, Tiemeier H. Cerebral hemodynamics and incident depression: the Rotterdam Study. Biol Psychiatry. 2012;72(4):318–323. doi:10.1016/j.biopsych.2012.01.019

64. Campayo A, Gomez-Biel CH, Lobo A. Diabetes and depression. Curr Psychiatry Rep. 2011;13(1):26–30. doi:10.1007/s11920-010-0165-z

65. Nouwen A, Adriaanse MC, van Dam K, et al. Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabet Med. 2019;36(12):1562–1572. doi:10.1111/dme.14054

66. Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–545. doi:10.1016/S2213-8587(20)30118-2

67. Rawlings AM, Sharrett AR, Albert MS, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC Study. Diabetes Care. 2019;42(7):1248–1254. doi:10.2337/dc19-0120

68. Esiri MM, Matthews F, Brayne C, et al.; Neuropathology Group. Medical Research Council Cognitive F, Aging S. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001;357(9251):169–175. doi:10.1016/s0140-6736(00)03589-3

69. Abner EL, Nelson PT, Kryscio RJ, et al. Diabetes is associated with cerebrovascular but not Alzheimer’s disease neuropathology. Alzheimers Dement. 2016;12(8):882–889. doi:10.1016/j.jalz.2015.12.006

70. Ojo O, Brooke J. Evaluating the association between diabetes, cognitive decline and dementia. Int J Environ Res Public Health. 2015;12(7):8281–8294. doi:10.3390/ijerph120708281

71. Chan DD, Tsou HH, Chang CB, et al. Integrated care for geriatric frailty and sarcopenia: a randomized control trial. J Cachexia Sarcopenia Muscle. 2017;8(1):78–88. doi:10.1002/jcsm.12132

72. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747–762. doi:10.1016/j.jacc.2013.09.070

73. Sesti G, Antonelli Incalzi R, Bonora E, et al. Management of diabetes in older adults. Nutr Metab Cardiovasc Dis. 2018;28(3):206–218. doi:10.1016/j.numecd.2017.11.007

74. DeCarlo K, Wallia A. Inpatient management of T2DM and hyperglycemia in older adults. Curr Diab Rep. 2019;19(10):104. doi:10.1007/s11892-019-1209-3

75. American Diabetes Association. 12. Older adults: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S139–S147. doi:10.2337/dc19-S012

76. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5):641–650. doi:10.1002/jor.1100090504

77. Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784. doi:10.3390/cells8080784

78. Liu WZ, Ma ZJ, Li JR, Kang XW. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res Ther. 2021;12(1):102. doi:10.1186/s13287-021-02153-8

79. Xiao Y, Zheng L, Zou X, Wang J, Zhong J, Zhong T. Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy. J Extracell Vesicles. 2019;8(1):1625677. doi:10.1080/20013078.2019.1625677

80. Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8(12):1605. doi:10.3390/cells8121605

81. Zhong J, Xia B, Shan S, et al. High-quality milk exosomes as oral drug delivery system. Biomaterials. 2021;277:121126. doi:10.1016/j.biomaterials.2021.121126

82. Shao J, Zaro J, Shen Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. Int J Nanomedicine. 2020;15:9355–9371. doi:10.2147/IJN.S281890

83. Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. doi:10.1016/j.gpb.2015.02.001

84. Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol. 2021;12:749192. doi:10.3389/fimmu.2021.749192

85. Vidal M, Mangeat P, Hoekstra D. Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation. J Cell Sci. 1997;110(Pt 16):1867–1877. doi:10.1242/jcs.110.16.1867

86. Nabhan JF, Hu R, Oh RS, Cohen SN, Lu Q. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci U S A. 2012;109(11):4146–4151. doi:10.1073/pnas.1200448109

87. van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125

88. Larios J, Mercier V, Roux A, Gruenberg J. ALIX- and ESCRT-III-dependent sorting of tetraspanins to exosomes. J Cell Biol. 2020;219(3). doi:10.1083/jcb.201904113

89. Buschow SI, Nolte-’t Hoen EN, van Niel G, et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 2009;10(10):1528–1542. doi:10.1111/j.1600-0854.2009.00963.x

90. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190(6):1079–1091. doi:10.1083/jcb.201002049

91. Babuta M, Furi I, Bala S, et al. Dysregulated autophagy and lysosome function are linked to exosome production by micro-RNA 155 in alcoholic liver disease. Hepatology. 2019;70(6):2123–2141. doi:10.1002/hep.30766

92. Buratta S, Tancini B, Sagini K, et al. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic- and endo-lysosomal systems go extracellular. Int J Mol Sci. 2020;21(7):2576. doi:10.3390/ijms21072576

93. Witwer KW, Buzas EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2. doi:10.3402/jev.v2i0.20360

94. Quintana JF, Makepeace BL, Babayan SA, et al. Extracellular Onchocerca-derived small RNAs in host nodules and blood. Parasit Vectors. 2015;8:58. doi:10.1186/s13071-015-0656-1

95. Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031. doi:10.3402/jev.v4.27031

96. Livshits MA, Khomyakova E, Evtushenko EG, et al. Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2015;5:17319. doi:10.1038/srep17319

97. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in Exosome Isolation Techniques. Theranostics. 2017;7(3):789–804. doi:10.7150/thno.18133

98. Shu S, Yang Y, Allen CL, et al. Purity and yield of melanoma exosomes are dependent on isolation method. J Extracell Vesicles. 2020;9(1):1692401. doi:10.1080/20013078.2019.1692401

99. Xu Y, Shen L, Li F, Yang J, Wan X, Ouyang M. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. J Cell Physiol. 2019;234(11):21380–21394. doi:10.1002/jcp.28747

100. Zeringer E, Barta T, Li M, Vlassov AV. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015;2015(4):319–323. doi:10.1101/pdb.top074476

101. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727. doi:10.3390/cells8070727

102. Saeedi S, Israel S, Nagy C, Turecki G. The emerging role of exosomes in mental disorders. Transl Psychiatry. 2019;9(1):122. doi:10.1038/s41398-019-0459-9

103. Ung TH, Madsen HJ, Hellwinkel JE, Lencioni AM, Graner MW. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer Sci. 2014;105(11):1384–1392. doi:10.1111/cas.12534

104. Sha S, Shen X, Cao Y, Qu L. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer’s disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/beta-catenin pathway. Aging. 2021;13(11):15285–15306. doi:10.18632/aging.203088

105. Riancho J, Vazquez-Higuera JL, Pozueta A, et al. MicroRNA profile in patients with Alzheimer’s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis. 2017;57(2):483–491. doi:10.3233/JAD-161179

106. Sarkar S, Jun S, Rellick S, Quintana DD, Cavendish JZ, Simpkins JW. Expression of microRNA-34a in Alzheimer’s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res. 2016;1646:139–151. doi:10.1016/j.brainres.2016.05.026

107. Song Z, Qu Y, Xu Y, et al. Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer’s disease. Animal Model Exp Med. 2021;4(3):233–242. doi:10.1002/ame2.12175

108. McKeever PM, Schneider R, Taghdiri F, et al. MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer’s disease. Mol Neurobiol. 2018;55(12):8826–8841. doi:10.1007/s12035-018-1032-x

109. Xu H, Zhao G, Zhang Y, et al. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/beta-catenin signaling pathway by targeting EZH2. Stem Cell Res Ther. 2019;10(1):381. doi:10.1186/s13287-019-1446-z

110. Venkat P, Zacharek A, Landschoot-Ward J, et al. Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats. Exp Neurol. 2020;334:113456. doi:10.1016/j.expneurol.2020.113456

111. Garnier D, Ratcliffe E, Briand J, Cartron PF, Oliver L, Vallette FM. The activation of mesenchymal stem cells by glioblastoma microvesicles alters their exosomal secretion of miR-100-5p, miR-9-5p and let-7d-5p. Biomedicines. 2022;10(1):112.

112. Abner EL, Jicha GA, Shaw LM, Trojanowski JQ, Goetzl EJ. Plasma neuronal exosomal levels of Alzheimer’s disease biomarkers in normal aging. Ann Clin Transl Neurol. 2016;3(5):399–403. doi:10.1002/acn3.309

113. Fiandaca MS, Kapogiannis D, Mapstone M, et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11(6):600–7 e1. doi:10.1016/j.jalz.2014.06.008

114. Goetzl EJ, Mustapic M, Kapogiannis D, et al. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease. FASEB J. 2016;30(11):3853–3859. doi:10.1096/fj.201600756R

115. Hamlett ED, Ledreux A, Potter H, et al. Exosomal biomarkers in Down syndrome and Alzheimer’s disease. Free Radic Biol Med. 2018;114:110–121. doi:10.1016/j.freeradbiomed.2017.08.028

116. Ahmad W. Glucose enrichment impair neurotransmission and induce Abeta oligomerization that cannot be reversed by manipulating O-beta-GlcNAcylation in the C. elegans model of Alzheimer’s disease. J Nutr Biochem. 2022;108:109100. doi:10.1016/j.jnutbio.2022.109100

117. Chi H, Yao R, Sun C, et al. Blood neuroexosomal mitochondrial proteins predict Alzheimer disease in diabetes. Diabetes. 2022;71(6):1313–1323. doi:10.2337/db21-0969

118. Pietzner M, Wheeler E, Carrasco-Zanini J, et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat Commun. 2021;12(1):6822. doi:10.1038/s41467-021-27164-0

119. Nakano M, Nagaishi K, Konari N, et al. Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes. Sci Rep. 2016;6:24805. doi:10.1038/srep24805

120. Lu XC, Zheng JY, Tang LJ, et al. MiR-133b Promotes neurite outgrowth by targeting RhoA expression. Cell Physiol Biochem. 2015;35(1):246–258. doi:10.1159/000369692

121. Ma X, Wang Y, Shi Y, et al. Exosomal miR-132-3p from mesenchymal stromal cells improves synaptic dysfunction and cognitive decline in vascular dementia. Stem Cell Res Ther. 2022;13(1):315. doi:10.1186/s13287-022-02995-w

122. Hancock ML, Preitner N, Quan J, Flanagan JG. MicroRNA-132 is enriched in developing axons, locally regulates Rasa1 mRNA, and promotes axon extension. J Neurosci. 2014;34(1):66–78. doi:10.1523/JNEUROSCI.3371-13.2014

123. Pan Q, Kuang X, Cai S, et al. miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury. Stem Cell Res Ther. 2020;11(1):260. doi:10.1186/s13287-020-01761-0

124. Malcangio M. Role of the immune system in neuropathic pain. Scand J Pain. 2019;20(1):33–37. doi:10.1515/sjpain-2019-0138

125. Lang HL, Zhao YZ, Xiao RJ, et al. Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes. Neural Regen Res. 2023;18(3):609–617. doi:10.4103/1673-5374.350205

126. Liu S, Fan M, Xu JX, et al. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology. J Neuroinflammation. 2022;19(1):35. doi:10.1186/s12974-022-02393-2

127. Yin F, Liu Z, Zhang D, Shen Z, Niu Z, Guo L. Identification of key genes involved in neural regeneration and the repairing effect of BDNF-overexpressed BMSCs on spinal cord ischemia-reperfusion injury in rats. Biomed Pharmacother. 2023;160:114293. doi:10.1016/j.biopha.2023.114293

128. Ma W, Wei X, Gu H, et al. Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta. Stem Cell Res Ther. 2022;13(1):413. doi:10.1186/s13287-022-03105-6

129. Yu X, Qi Y, Zhao T, et al. NGF increases FGF2 expression and promotes endothelial cell migration and tube formation through PI3K/Akt and ERK/MAPK pathways in human chondrocytes. Osteoarthritis Cartilage. 2019;27(3):526–534. doi:10.1016/j.joca.2018.12.007

130. Li R, Li Y, Wu Y, et al. Heparin-poloxamer thermosensitive hydrogel loaded with bFGF and NGF enhances peripheral nerve regeneration in diabetic rats. Biomaterials. 2018;168:24–37. doi:10.1016/j.biomaterials.2018.03.044

131. Kellar D, Craft S. Brain insulin resistance in Alzheimer’s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19(9):758–766. doi:10.1016/S1474-4422(20)30231-3

132. Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Haring HU. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev. 2016;96(4):1169–1209. doi:10.1152/physrev.00032.2015

133. Liyanagamage D, Martinus RD. Role of mitochondrial stress protein HSP60 in diabetes-induced neuroinflammatIon. Mediators Inflamm. 2020;2020:8073516. doi:10.1155/2020/8073516

134. Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021;35(5–6):307–328. doi:10.1101/gad.346312.120

135. Cui GH, Guo HD, Li H, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease. Immun Ageing. 2019;16:10. doi:10.1186/s12979-019-0150-2

136. Kubota K, Nakano M, Kobayashi E, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One. 2018;13(9):e0204252. doi:10.1371/journal.pone.0204252

137. Duan S, Wang F, Cao J, Wang C. Exosomes derived from MicroRNA-146a-5p-enriched bone marrow mesenchymal stem cells alleviate intracerebral hemorrhage by inhibiting neuronal apoptosis and microglial M1 polarization. Drug Des Devel Ther. 2020;14:3143–3158. doi:10.2147/DDDT.S255828

138. Nakano M, Kubota K, Kobayashi E, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10(1):10772. doi:10.1038/s41598-020-67460-1

139. Yin Z, Han Z, Hu T, et al. Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture. Brain Behav Immun. 2020;83:270–282. doi:10.1016/j.bbi.2019.11.004

140. Pandey N, Rastogi M, Singh SK. Chandipura virus dysregulates the expression of hsa-miR-21-5p to activate NF-kappaB in human microglial cells. J Biomed Sci. 2021;28(1):52. doi:10.1186/s12929-021-00748-0

141. Ge X, Huang S, Gao H, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016;1650:31–40. doi:10.1016/j.brainres.2016.07.015

142. Ouyang Y, Li D, Wang H, et al. MiR-21-5p/dual-specificity phosphatase 8 signalling mediates the anti-inflammatory effect of haem oxygenase-1 in aged intracerebral haemorrhage rats. Aging Cell. 2019;18(6):e13022. doi:10.1111/acel.13022

143. Gao X, Xiong Y, Li Q, et al. Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN/Akt pathway after subarachnoid hemorrhage. Cell Death Dis. 2020;11(5):363. doi:10.1038/s41419-020-2530-0

144. Pan Q, Wang Y, Lan Q, et al. Exosomes derived from mesenchymal stem cells ameliorate hypoxia/reoxygenation-injured ECs via transferring MicroRNA-126. Stem Cells Int. 2019;2019:2831756. doi:10.1155/2019/2831756

145. Wang X, Zhou Y, Gao Q, et al. The role of exosomal microRNAs and oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev. 2020;2020:3232869. doi:10.1155/2020/3232869

146. Chen P, Chen F, Lei J, Li Q, Zhou B. Activation of the miR-34a-mediated SIRT1/mTOR signaling pathway by urolithin A attenuates D-galactose-induced brain aging in mice. Neurotherapeutics. 2019;16(4):1269–1282. doi:10.1007/s13311-019-00753-0

147. Thal DR, Walter J, Saido TC, Fandrich M. Neuropathology and biochemistry of Abeta and its aggregates in Alzheimer’s disease. Acta Neuropathol. 2015;129(2):167–182. doi:10.1007/s00401-014-1375-y

148. Hur JY. gamma-Secretase in Alzheimer’s disease. Exp Mol Med. 2022;54(4):433–446. doi:10.1038/s12276-022-00754-8

149. Sun Y, Ma C, Sun H, et al. Metabolism: a novel shared link between diabetes mellitus and Alzheimer’s disease. J Diabetes Res. 2020;2020:4981814. doi:10.1155/2020/4981814

150. Chen Z, Zhong C. Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21–43. doi:10.1016/j.pneurobio.2013.06.004

151. Stukas S, Robert J, Wellington CL. High-density lipoproteins and cerebrovascular integrity in Alzheimer’s disease. Cell Metab. 2014;19(4):574–591. doi:10.1016/j.cmet.2014.01.003

152. Dutta BJ, Singh S, Seksaria S, Das Gupta G, Singh A. Inside the diabetic brain: insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies. Pharmacol Res. 2022;182:106358. doi:10.1016/j.phrs.2022.106358

153. Lee M, Ban JJ, Yang S, Im W, Kim M. The exosome of adipose-derived stem cells reduces beta-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer’s disease. Brain Res. 2018;1691:87–93. doi:10.1016/j.brainres.2018.03.034

154. Jahangard Y, Monfared H, Moradi A, Zare M, Mirnajafi-Zadeh J, Mowla SJ. Therapeutic effects of transplanted exosomes containing miR-29b to a rat model of Alzheimer’s disease. Front Neurosci. 2020;14:564. doi:10.3389/fnins.2020.00564

155. Zhang J, Buller BA, Zhang ZG, et al. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol. 2022;347:113895. doi:10.1016/j.expneurol.2021.113895

156. Reza-Zaldivar EE, Hernandez-Sapiens MA, Gutierrez-Mercado YK, et al. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease. Neural Regen Res. 2019;14(9):1626–1634. doi:10.4103/1673-5374.255978

157. Wang H, Liu Y, Li J, et al. Tail-vein injection of MSC-derived small extracellular vesicles facilitates the restoration of hippocampal neuronal morphology and function in APP/PS1 mice. Cell Death Discov. 2021;7(1):230. doi:10.1038/s41420-021-00620-y

158. Parsi S, Smith PY, Goupil C, Dorval V, Hebert SS. Preclinical evaluation of miR-15/107 family members as multifactorial drug targets for Alzheimer’s disease. Mol Ther Nucleic Acids. 2015;4(10):e256. doi:10.1038/mtna.2015.33

159. Hebert SS, Horre K, Nicolai L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105(17):6415–6420. doi:10.1073/pnas.0710263105

160. Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008;28(5):1213–1223. doi:10.1523/JNEUROSCI.5065-07.2008

161. Zhang X, Huang X, Fang C, et al. miR-124 regulates the expression of BACE1 in the hippocampus under chronic cerebral hypoperfusion. Mol Neurobiol. 2017;54(4):2498–2506. doi:10.1007/s12035-016-9845-y

162. Yuyama K, Sun H, Mitsutake S, Igarashi Y. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J Biol Chem. 2012;287(14):10977–10989. doi:10.1074/jbc.M111.324616

163. Yuyama K, Sun H, Sakai S, et al. Decreased amyloid-beta pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J Biol Chem. 2014;289(35):24488–24498. doi:10.1074/jbc.M114.577213

164. Yuyama K, Sun H, Igarashi Y, et al. Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ss-bound extracellular vesicles. Alzheimers Res Ther. 2022;14(1):140. doi:10.1186/s13195-022-01073-w

165. An K, Klyubin I, Kim Y, et al. Exosomes neutralize synaptic-plasticity-disrupting activity of Abeta assemblies in vivo. Mol Brain. 2013;6:47. doi:10.1186/1756-6606-6-47

166. Perez-Gonzalez R, Kim Y, Miller C, Pacheco-Quinto J, Eckman EA, Levy E. Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-beta oligomerizes. FASEB J. 2020;34(9):12922–12931. doi:10.1096/fj.202000823R

167. Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(8):1792–1800. doi:10.1016/j.neurobiolaging.2014.02.012

168. Dinkins MB, Wang G, Bieberich E. Sphingolipid-enriched extracellular vesicles and Alzheimer’s disease: a decade of research. J Alzheimers Dis. 2017;60(3):757–768. doi:10.3233/JAD-160567

Next Page »